Microdose Psychedelic Insights, a cutting-edge media company aiming to move the psychedelics industry to the forefront of modern medicine, today announced that it will host the upcoming Psychedelic Capital conference. The virtual event is slated to take place on August 31, 2021, and provide attendees with access to the top companies, latest IPOs, newest opportunities, and deepest industry insights in the growing psychedelic medicine sector. As part of a series of conferences diving deep into the world of psychedelic medicine investment, the event seeks to introduce investors and attendees to a curated group of CEOs, capital advisors and investment luminaries from around the world. An introductory talk from Patrick Moher, CEO of Microdose Psychedelic Insights, and Richard Skaife, founding partner at The Conscious Fund, an early-stage venture capital investor within the plant-powered medicine sector, will kick off Psychedelic Capital’s August event. The conference will additionally host a series of corporate presentations from top industry insiders and CEOs, an investor roundtable seeking to address some of the pressing issues affecting the global psychedelics industry, and many more engaging topics. “Two-eyed seeing is a Mi’kmaw principle for mindfully bringing together Western science and Indigenous wisdom to use all our understandings so we can leave the world a better place,” said Steven Huang (he/him) Founder, Millennial HR Design moderator of the DEI panel. “We’ll discuss how cross-cultural collaboration — across the diverse array of psychedelic stakeholders — could be the key to unlocking tremendous value and growth in an ethical, responsible way.”
To view the full press release, visit https://ibn.fm/Bk2pQ
About Microdose Psychedelic Insights
Microdose Psychedelic Insights is your guide to the psychedelic medicine industry. With a vision to shift the world’s perception of psychedelic medicine, Microdose Psychedelic Insights distributes and creates the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry to the forefront of modern medicine. For more information, visit www.Microdose.buzz.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.